Literature DB >> 2477995

1,2-dioxetanes: novel chemiluminescent enzyme substrates. Applications to immunoassays.

I Bronstein1, B Edwards, J C Voyta.   

Abstract

We have synthesized and studied two 1,2-dioxetane-based chemiluminescent enzyme substrates: 3-(2'-spiroadamantane)-4-methoxy-4-(3"-phosphoryloxy)phenyl- 1,2-dioxetane (AMPPD), and, 3-(2'-spiroadamantane)-4-methoxy-4-(3"-beta-D'-galactopyrano -yloxy)phenyl-1,2- dioxetane (AMPGD), which can be activated to chemiluminescence at 470 nm by alkaline phosphatase and beta-D-galactosidase, respectively. In addition, we observed that certain macromolecules enhance the luminescence of AMPPD. For example, the addition of 0.1% bovine serum albumin amplifies the luminescent signal and improves the detection limit for alkaline phosphatase by approximately one order of magnitude under certain conditions. This effect is due to the presence of a hydrophobic microenvironment provided by the enhancer which 'stabilizes' the dephosphorylated AMPPD emitter. Alkaline phosphatase catalysed chemiluminescence from AMPPD is constant for a prolonged period of time. Using AMPPD we were able to detect 0.01 attomole quantities of alkaline phosphatase immobilized on membrane supports and imaged on photographic film and, in solution, measured in a luminometer. AMPPD and AMPGD offer alternatives to colorimetric and fluorescent substrates for alkaline phosphatase and beta-D-galactosidase labels used in enzyme immunoassays. The simplicity and sensitivity of this chemiluminescent readout allowed the development of rapid clinical assays (e.g. beta-hCG, LH, TSH and others).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477995     DOI: 10.1002/bio.1170040116

Source DB:  PubMed          Journal:  J Biolumin Chemilumin        ISSN: 0884-3996


  27 in total

1.  Medium effect on the enzymatically triggered electron-exchange luminescence of the biologically important dioxetane.

Authors:  A V Trofimov
Journal:  Dokl Biochem Biophys       Date:  2004 Jan-Feb       Impact factor: 0.788

2.  Chemiluminescence dot blot hybridization assay for detection of B19 parvovirus DNA in human sera.

Authors:  M Musiani; M Zerbini; D Gibellini; G Gentilomi; S Venturoli; G Gallinella; E Ferri; S Girotti
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

Review 3.  Protein (western) blotting.

Authors:  D Egger; K Bienz
Journal:  Mol Biotechnol       Date:  1994-06       Impact factor: 2.695

4.  Methodological advances in drug discovery for Chagas disease.

Authors:  Juan M Bustamante; Rick L Tarleton
Journal:  Expert Opin Drug Discov       Date:  2011-06       Impact factor: 6.098

5.  Gene expression and cell fusion analyzed by lacZ complementation in mammalian cells.

Authors:  W A Mohler; H M Blau
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

6.  Limitations of highly sensitive enzymatic presence-absence tests for detection of waterborne coliforms and Escherichia coli.

Authors:  S O Van Poucke; H J Nelis
Journal:  Appl Environ Microbiol       Date:  1997-02       Impact factor: 4.792

Review 7.  New frontiers and developing applications in 19F NMR.

Authors:  Jian-Xin Yu; Rami R Hallac; Srinivas Chiguru; Ralph P Mason
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2012-11-02       Impact factor: 9.795

8.  Engineering bacteriophage for a pragmatic low-resource setting bacterial diagnostic platform.

Authors:  Joey N Talbert; Samuel D Alcaine; Sam R Nugen
Journal:  Bioengineered       Date:  2016-05-31       Impact factor: 3.269

9.  A cephalosporin-chemiluminescent conjugate increases beta-lactamase detection sensitivity by four orders of magnitude.

Authors:  Santanu Maity; Xiaojian Wang; Subhamoy Das; Maomao He; Lee W Riley; Niren Murthy
Journal:  Chem Commun (Camb)       Date:  2020-02-26       Impact factor: 6.222

10.  Chemically modified ribozyme targeting TNF-alpha mRNA regulates TNF-alpha and IL-6 synthesis in synovial fibroblasts of patients with rheumatoid arthritis.

Authors:  Minako Takahashi; Tadao Funato; Yoko Suzuki; Hiroshi Fujii; Keiko Kumura Ishii; Mitsuo Kaku; Takeshi Sasaki
Journal:  J Clin Immunol       Date:  2002-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.